Subtitle
Request a sample or support
9 - 12 September, 2024
Kistamässan Exhibition & Congress Centre Kista, Sweden
Subtitle
Request a sample or support
19 - 22 September, 2024
Kistamässan Exhibition & Congress Centre Kista, Sweden
Subtitle
From bench to commercial scale – without compromise
Subtitle
With Cytiva™ Protein Select™ resin and tag
12 September, 2024
Unlock the full potential of your viral vector production with our iCELLis™ bioreactor platform.
Designed for gene therapy innovators, iCELLis™ bioreactors offer unmatched scalability, automation, and process consistency – empowering you to move from R&D to GMP manufacturing faster and more efficiently than ever before.
Why iCELLis™ bioreactors?
Global support, local expertise
From proof-of-concept to commercial launch, our global team of Field Application Specialists and Fast Trak™ process development services are here to support your success.
Scalable single-use, fixed-bed systems ranging from 0.5 to 500 m². Engineered for a compact footprint and minimal labor, driving significant cost efficiencies.
They support clinical and commercial production for viral vectors, exosomes, vaccines, and other applications.
9 - 22 September, 2024
Kistamässan Exhibition & Congress Centre Kista, Sweden
Monitoring water quality relies on the measurement of different parameters, including total suspended solids (TSS) and total dissolved solids (TDS), which are the molecules and ions that remain in a water sample after filtration.
Regulations on workflows and thresholds vary depending on country, region, or city. Regardless of the location, wastewater quality testing is a long, manual process. Proper filtration is vital in this process. Whatman filters 934-AH meet US EPA Laboratory Standard Method 2540 parts C, D, and E and GF/C meet standard for EN872.
We heard from 800 biopharma leaders for our Sustainability Review.
We’re bringing our KUBio box trailer mRNA facility to you.
Compact liquid chromatography system to support routine protein purification in research laboratories.
The ELEVECTA™ cell line portfolio combines innovative design and deep expertise to deliver transient, packaging, and producer options that provide competitive performance, high quality, and flexibility.
ÄKTA go™ protein purification system
| Throughput | Up to 300 units per load / 1200 units per 8-hour shift |
| Pump type | Peristaltic pump |
| Fill Volume Range | 1.0 – 50 mL |
| In-process control | Programmable up to 100% of units |
| Product contact materials | Single-use flow path assembly |
| Interior classification | ISO 5 / Grade A |
| Cleanroom classification | ISO 8 / Grade D |
| Dimensions | 1.7 x 1.5 x 2.2 m (5’6” x 4’9” x 7’2”) |
| Required cleanroom space | 15m² (160 sq. ft.) |
| Electrical | 208–240 VAC, single phase, 50–60 Hz, FLA 36 |
Praesent lacus arcu, mollis ut volutpat pharetra, vulputate quis massa. Nam interdum fringilla bibendum. Maecenas non odio dui. Suspendisse eros ex, ullamcorper et dui non.
Sed feugiat libero eu turpis tincidunt iaculis. In vel aliquam est, at porta neque. Donec hendrerit ultrices consectetur. Integer feugiat massa quis arcu ullamcorper, tristique facilisis massa feugiat. Phasellus risus mauris, pretium vitae tortor non, tristique fringilla tortor. Aliquam volutpat eros ac risus consectetur, quis gravida erat lobortis. Quisque id rutrum enim, sed fermentum nisl. Nulla volutpat turpis ac ligula venenatis maximus. In non dui ante. Sed ullamcorper quis nisi.
Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.
Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere. Curabitur rutrum pharetra nisl, vitae tincidunt ante consectetur et.
Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.
Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere.
Praesent lacus arcu, mollis ut volutpat pharetra, vulputate quis massa. Nam interdum fringilla bibendum.
Sed feugiat libero eu turpis tincidunt iaculis. In vel aliquam est, at porta neque. Donec hendrerit ultrices consectetur. Integer feugiat massa quis arcu ullamcorper, tristique facilisis massa feugiat. Phasellus risus mauris, pretium vitae tortor non, tristique fringilla tortor. Aliquam volutpat eros ac risus consectetur, quis gravida erat lobortis. Quisque id rutrum enim, sed fermentum nisl. Nulla volutpat turpis ac ligula venenatis maximus. In non dui ante.
Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.
Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere. Curabitur rutrum.
Praesent lacus arcu, mollis ut volutpat pharetra, vulputate quis massa. Nam interdum fringilla bibendum. Maecenas non odio dui. Suspendisse eros ex, ullamcorper et dui non.
Sed feugiat libero eu turpis tincidunt iaculis. In vel aliquam est, at porta neque. Donec hendrerit ultrices consectetur. Integer feugiat massa quis arcu ullamcorper, tristique facilisis massa feugiat. Phasellus risus mauris, pretium vitae tortor non, tristique fringilla tortor. Aliquam volutpat eros ac risus consectetur, quis gravida erat lobortis. Quisque id rutrum enim, sed fermentum nisl. Nulla volutpat turpis ac ligula venenatis maximus. In non dui ante. Sed ullamcorper quis nisi.
Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.
Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere. Curabitur rutrum pharetra nisl, vitae tincidunt ante consectetur et.
ELEVECTA™ transient cell line
Preseves flexibility while delivering excellent performance and quality - all aimed at quickly advancing candidates to clinical trials.
ELEVECTA™ packaging cell line
Contains all genes except the transgene; allows streamlining the screaning of assets that use the same capsid to target the same tissue type.
ELEVECTA™ producer cell line
Contains all genes to produce AAV; simply induce. The result is a simplified, robust, upstream process that easily scales to treat hundreds of thousands.
Perfect for early-stage process development, this bioreactor offers 0.5–4 m² of fixed-bed surface area and seamless scalability to larger systems.
Offering 6.6–50 m² of surface area making it the most representative scale-down model for validation and small-batch production.
Description
ÄKTA go™Achieve desired purity with ease in routine purifications – make the most of valuable bench/cold-room space |
ÄKTA pure™Flexibility in research – match most current and future purification challenges |
ÄKTA start™Entry level chromatography solution for the preparative purification of proteins in lab scale. |
ÄKTA oligosynt™Compact, fully automated oligonucleotide synthesizer to support research and process development laboratories. |
|
|---|---|---|---|---|
| Support for affinity chromatography, ion exchange chromatography, and multimodal (mixed mode) chromatography | yes | yes | yes | yes |
| Support for affinity chromatography, ion exchange chromatography, multimodal (mixed mode) and size exclusion chromatography | yes | yes | no | no |
| Support for hydrophobic interaction chromatography | yes | yes | yes | no |
| Scale up, method development and optimisation using design of experiment (DoE) | no | yes | yes | yes |
| Automated: resin/column scouting, multistep purification, external equipment | no | yes | no | yes |
| Wavelength (nm) | Fixed at 280nm | Optional Fixed at 280, dual 260/280 or multi – up to 3 between 190-700 | Fixed at 280nm | Optional Fixed at 280, dual 260/280 or multi – up to 3 between 190-700 |
| Recommended flow rate (mL/min) | 0.01-25.0 | 0.001-25/0.01-150 | 0.01-25.0 | 0.001-25/0.01-150 |
| Maximum operating pressure (Mpa) | 5 | 20/5 | 7 | 20/4 |
Beyond supporting your gene therapy processes with our technology and application knowledge, we're passionate about advancing solutions in areas where the status quo isn’t good enough. That's why we're excited to tell you about our ELEVECTA™ cell lines ― a significant advancement in viral vector manufacturing.
From posters and webinars to application notes and online learning, simply click on the links below to access some of our latest resources to support your cell and gene therapy advances.
Your R&D powerhouse
The pilot-scale workhorse
Industrial-scale manufacturing, simplified
Associate Scientist, Product Develipment, Cytiva
Chief Technology Officer, Danaher
Associate Scientist, Product Development, Cytiva
Senior Director of Innovation Advocacy, Cytiva
Associate Scientist, Product Develipment, Cytiva
Agenda and schedules are subject to change. All times listed are in CEST.
On the first day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.
| Time | Details | |
|---|---|---|
| 8:00 - 9:00 | Registration | |
| 9:10 - 10:40 | Nestor Santiago and Gillian Goodwin | Biacore™ system assay development revisited - Recipe for successful SPR data |
| 10:50 - 12:20 | Cynthia Shuman and Eric Roush | Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system |
| 12:30 - 14:30 | Lunch break | |
| 14:45 - 16:00 | Christin Radon and Emeric Gueneau | Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation |
| 16:10 - 16:40 | Anja Drescher and Mike Murphy | Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison |
| 16:50 - 17:20 | John Sinfield and Shannon Bryan | Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish |
On the second day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.
| Time | Details | |
|---|---|---|
| 7:00 - 8:30 | Registration | |
| 8:40 - 10:40 | Nestor Santiago and Gillian Goodwin | Biacore™ system assay development revisited - Recipe for successful SPR data |
| 10:50 - 12:20 | Cynthia Shuman and Eric Roush | Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system |
| 12:30 - 14:30 | Lunch break | |
| 14:45 - 16:00 | Christin Radon and Emeric Gueneau | Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation |
| 16:10 - 16:40 | Anja Drescher and Mike Murphy | Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison |
| 16:50 - 17:20 | John Sinfield and Shannon Bryan | Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish |
On the third day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.
| Time | Details | |
|---|---|---|
| 8:30 - 9:15 | Registration | |
| 9:25 - 10:40 | Nestor Santiago and Gillian Goodwin | Biacore™ system assay development revisited - Recipe for successful SPR data |
| 10:50 - 12:20 | Cynthia Shuman and Eric Roush | Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system |
| 12:30 - 14:30 | Lunch break | |
| 14:45 - 16:00 | Christin Radon and Emeric Gueneau | Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation |
| 16:10 - 16:40 | Anja Drescher and Mike Murphy | Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison |
| 16:50 - 17:20 | John Sinfield and Shannon Bryan | Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish |
Agenda and schedules are subject to change. All times listed are in CEST.
| Time | Details | |
|---|---|---|
| 8:30 - 9:00 | Welcome and opening | |
| 9:00 - 10:30 | Stephan Poetsch | ÄKTA™ chromatography systems family, system specifications and UNICORN with the new developments in the portfolio |
| 10:30 - 11:00 | Break | |
| 11:00 - 12:00 | Stephan Poetsch | ÄKTA™ basic care and troubleshooting - To prevent problems during protein purification |
| 12:00 - 13:30 | Christin Radon and Emeric Gueneau | Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation |
| 13:30 - 15:00 | Anja Drescher and Mike Murphy | Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison |
This free interactive course provides a high-level overview of preclinical study in cellular and gene therapy (CGT) development.
Attending DiPIA 2024 was incredibly inspiring! Connecting with global experts in SPR technology gave me new insights and ideas for my research.
Dr Mary Collins
University of Cambridge
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr John Davis
Institute for Biological Research
Attending DiPIA 2024 was incredibly inspiring! Connecting with global experts in SPR technology gave me new insights and ideas for my research.
Dr Anna Collins
University of Cambridge
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr Steven Davis
Institute for Biological Research
Attending DiPIA 2024 was incredibly inspiring! Connecting with global experts in SPR technology gave me new insights and ideas for my research.
Dr Mary Collins
University of Cambridge
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr John Davis
Institute for Biological Research
Associate Scientist, Product Develipment, Cytiva
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.
Chief Technology Officer, Danaher
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.
Associate Scientist, Product Development, Cytiva
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.
Senior Director of Innovation Advocacy, Cytiva
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.
Associate Scientist, Product Develipment, Cytiva
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.
